Glucosamine and warfarin alert
Glucosamine is widely used for the symptoms of osteoarthritis. Recent reports have suggested that it may interact with warfarin and thus make blood less likely to clot. The mechanism for this is uncertain. However, Arthritis Australia recommends that patients on warfarin who are starting or stopping glucosamine should have their INR (blood clotting) checked regularly for the first month. Patients who are on stable doses of both are unlikely to have problems.
Prof. Graeme Jones
Arthritis Australia Medical Director
Discover more...
-
Over 20 peak groups join Arthritis Australia’s call for urgent action on arthritis and musculoskeletal conditions.
Arthritis Australia and over 40 leading health stakeholders including over 20 peak bodies have issued a formal communique calling for urgent action to provide more...
-
Parliamentary summit on better care for arthritis and musculoskeletal conditions
Click here to download the summit agenda Click here to download the communique Musculoskeletal conditions, including arthritis and back pain , affect around 7 million...
-
World Arthritis Day | 2024
World Arthritis Day 2024: Empowering Through Information October 12th marks World Arthritis Day, a global initiative to recognise the challenges faced by millions living with...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
